Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell Carcinoma
Takayuki Sugiyama(Hamamatsu University School of Medicine), Hideaki Miyake(Kobe University)
Cited by 8
Related Papers
Assessments of therapeutic effects according to timings for combined therapy with axitinib and immune check point inhibitor in a mouse renal cell carcinoma model
|Scientific Reports|2023|7